Skip to main content

sirolimus

NDC 68382-352 · Zydus Pharmaceuticals USA Inc.

Generic namesirolimus
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)SIROLIMUS
Strength2 mg/1
Pharmacologic classDecreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
Marketing categoryANDA

Packages

68382-352-01 — 100 TABLET, FILM COATED in 1 BOTTLE (68382-352-01)

68382-352-77 — 10 BLISTER PACK in 1 CARTON (68382-352-77) / 10 TABLET, FILM COATED in 1 BLISTER PACK (68382-352-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

60687-902 — sirolimus, 65841-771 — sirolimus, 65841-772 — sirolimus, 65841-773 — sirolimus, 66689-347 — Sirolimus, 67877-746 — Sirolimus, 67877-747 — Sirolimus, 67877-748 — Sirolimus, 68084-915 — Sirolimus, 68382-351 — sirolimus, 68382-520 — sirolimus, 68462-682 — sirolimus, 68462-683 — sirolimus, 68462-684 — sirolimus, 69238-1594 — SIrolimus, 70518-3546 — Sirolimus, 70518-3795 — Sirolimus, 70518-4376 — sirolimus, 70518-4449 — sirolimus, 72162-2641 — sirolimus, +18 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.